Panama’s CSS Authorizes $91 Million in Medications for Common and Chronic Diseases
The bidding process, which was broadcast on the CSS YouTube channel, involved 57 participants, which the institution says guarantees the transparency of the process.
The Social Security Fund (CSS) reported that it will invest $91,979,892.00 for the supply, storage, transport and delivery of 348 lines of chemically synthesized medicines over a period of 15 months. The included medications cover treatments for common and chronic diseases such as hypertension, type 2 diabetes, dyslipidemia, asthma, depression, anxiety, infectious diseases, allergies, among others. According to the Caja, this is Single Price Tender No. 01-2026, with the objective of guaranteeing a continuous supply at the national level.
“The Single Price model allows for setting uniform prices for all CSS implementing units nationwide, thus enabling the acquisition of a larger quantity of medicines at a better cost, while maintaining quality,” the institution highlighted. It was detailed that 57 companies participated in the aforementioned event, demonstrating, according to the institution, a transparent, open procedure with clear rules that promote competition. According to the institution, the event was public and broadcast live on the CSS YouTube channel, through which the participating items in this tender can be verified, which in turn guarantees the transparency of said event. The CSS points out that this procedure ensures a timely supply of medicines and guarantees that insured individuals receive their treatments without interruption.
